ADC quantification to classify patients candidate to receive bevacizumab treatment for recurrent glioblastoma.
Beatriz Asenjo GarcíaF Navarro GuiradoFátima Nagib RayaMaría Vidal DenisFrancisco Bravo RodríguezPedro Galán MontenegroPublished in: Acta radiologica (Stockholm, Sweden : 1987) (2019)